Mon. May 25th, 2026
Spread the love

Jeff Bezos remains the world’s richest person, ahead of Bill Gates and Warren Buffett, according to the latest Forbes list of the ultra-wealthy, while far behind President Donald Trump jumped 51 spots in the ranking. Trump is now 715th in the world, far behind Africa’s richest man Aliko Dangote, who is 136th with a net worth of $10.9 billion. Mike Adenuga is 156th, with a net worth of $9.1 billion

While things are largely stable on top of the list, Facebook founder Mark Zuckerberg dropped three spots and former New York mayor Michael Bloomberg rose by two. According to the list announced Tuesday by Forbes, the riches of Bezos, 55, increased by $19 billion in one year and he is now worth $131 billion.

Bezos, who holds 16% of Amazon and whose wealth now makes him a target of the right wing of US politics, has widened the money gap between himself and Gates, the philanthropist and co-founder of Microsoft. Gates, 63, has seen his wealth grow to $96.5 billion, up from 90 billion last year, said Forbes.

Third place is held by Buffett, 88 and long considered an investment guru, although he did get stung in late February by a deep plunge in shares of US processed food maker Kraft Heinz, in which he has a large stake. Buffett’s fortune slipped by $1.5 billion to $82.5 billion, the magazine estimated. It is more or less after this trio that things start to get shaken up on the Forbes list.

The CEO of French luxury good company LVMH, Bernard Arnault, held on to fourth place. But Zuckerberg lost $9 billion in net worth and slipped from fifth to eighth. Ahead of Zuckerberg now are Mexican tycoon Carlos Slim, Zara and Inditex founder Amancio Ortega of Spain, and Oracle co-founder Larry Ellison. Bloomberg rose from 11th to ninth place as his fortune increased to $55.5 billion, from $50 billion, said Forbes.

Americans still dominate the list with 14 of the top 20 billionaires from the US. Non-Americans among the top 20 include India’s Mukesh Ambani, chairman of Reliance Industries, in 13th place, and China’s Ma Huateng, head of the Chinese internet giant Tencent, who rounds out the top 20.

While 994 people from last year’s ranking saw their wealth drop – a record, according to Forbes – Trump rose in the Forbes ranking from 766 last year to 715 this year. Forbes estimates Trump’s wealth at $3.1 billion, unchanged from last year. Forbes depreciated the Trump-owned National Doral Miami golf club by $26 million following a drop in bookings attributed to disagreements with the president’s policies. Trump’s nine New York skyscrapers, including the famous Trump Tower on Fifth Avenue, account for nearly half of his wealth, while his clubs and golf courses are valued at $550 million.

However, one of Trump’s Florida golf clubs, the National Doral Miami, took a hit and has been depreciated by $26 million following a sharp drop in bookings attributed to disagreements with the president’s policies, Forbes said.

Trump is not the richest US elected official: that honor goes to JB Pritzker, a Democrat who took office as governor of Illinois in January. Pritzker, heir to the Hyatt hotel fortune, was estimated to be worth $3.2 billion.

 

By admin

You missed

From Tramadol to Canadian to Exol-5 The New Drug Destroying Nigerian Youths An Investigative Article .From Tramadol to Canadian to Exol-5: The New Drug Destroying Nigerian Youths An Investigative Report on the Shifting Landscape of Substance Abuse in Nigeria Nigeria faces a severe and evolving drug crisis, particularly among its youth. What began with the widespread abuse of Tramadol has progressed through mixtures like “Canadian” to newer pharmaceutical diversions such as Exol-5. This shift reflects deeper issues: easy access to prescription drugs, weak regulation, socioeconomic pressures, and aggressive street-level marketing. NDLEA operations and health studies reveal a public health emergency that threatens an entire generation. Phase 1: The Tramadol Epidemic (2010s–Early 2020s) Tramadol, a synthetic opioid prescribed for moderate to severe pain, became Nigeria’s most notorious street drug. Cheap, potent, and widely smuggled (often from India and other Asian countries), it offered users energy, euphoria, and pain relief — appealing to commercial drivers, laborers, students, and young men seeking confidence or stamina. Scale of the Problem: Millions of tablets seized annually by NDLEA. High prevalence among young males aged 15–35. Linked to increased crime, sexual violence, organ damage (kidney failure, seizures), and mental health breakdowns. Contributed to broader opioid misuse alongside codeine cough syrups. Government responses included tighter import controls and public awareness campaigns, but these only displaced demand to other substances rather than eliminating it. Phase 2: The Rise of “Canadian” (Mid-2020s) “Canadian” or “Canadian Loud” emerged as a popular code for high-grade cannabis (often indica-dominant strains) or cannabis mixed with other synthetics. It gained traction as users sought alternatives or combinations to Tramadol’s effects. This phase marked a move toward imported or locally cultivated premium weed, sometimes laced with stronger chemicals. Youths in urban centers like Lagos, Kano, Jos, and Onitsha embraced it for its perceived “cleaner” high compared to opioids. However, it fueled polydrug use — combining cannabis with opioids, sedatives, or alcohol — amplifying health risks. Phase 3: Exol-5 – The Current Threat (2024–2026) Exol-5 (Benzhexol Hydrochloride / Trihexyphenidyl 5mg), originally a prescription medication for Parkinson’s disease and drug-induced movement disorders, has become the latest pharmaceutical being heavily abused. Why Exol-5? Euphoric Effects: Users report intense euphoria, hallucinations, and a sense of detachment — making it attractive as a cheap “upper” or escape. Accessibility: Sold over-the-counter or on the black market despite being a controlled prescription drug. NDLEA has seized millions of pills in single operations (e.g., 3.1 million pills in Kano in late 2024, and over 5.6 million combined with Tramadol in other busts). Street Names: Exol, Artane, Benzhexol, “Farin Mallam” (in Northern Nigeria). Demographics: Prevalent among youths, laborers, and even psychiatric patients who divert prescriptions. Studies show abuse rates as high as 25% among certain outpatient groups. Health Consequences: Anticholinergic toxicity: Confusion, dry mouth, blurred vision, urinary retention, constipation, and in high doses — delirium, psychosis, seizures, and heart issues. Long-term: Cognitive impairment, addiction, exacerbated mental health disorders. Often mixed with Tramadol, codeine, or cannabis, creating dangerous synergies. In cities like Jos, Exol-5 sits alongside diazepam, Rohypnol, and Tramadol on street markets, easily available to teenagers and young adults. Why This Evolution Continues Supply-Side Failures: Porous borders, corrupt officials, and overproduction of pharmaceuticals enable diversion. Demand Drivers: Unemployment, poverty, peer pressure, trauma, and the pursuit of performance enhancement (e.g., for “hustle” culture). Weak Regulation: Many pharmacies sell restricted drugs without prescriptions. Online and street vendors fill gaps. Displacement Effect: Cracking down on one substance (Tramadol/codeine) pushes users and dealers toward the next available option. NDLEA reports ongoing large seizures, but the problem persists due to high profitability and low risk for mid-level distributors. Broader Impacts on Nigerian Youths Education: Increased dropout rates and poor academic performance. Mental Health: Rising cases of psychosis and depression. Economy: Lost productivity among the working-age population. Crime and Violence: Drug-fueled robberies, cultism, and family breakdowns. Public Health System Strain: Overburdened hospitals treating overdoses and chronic complications. Young people aged 15–39 remain the hardest hit, with national surveys showing drug use prevalence significantly above global averages. What Must Be Done Stronger Enforcement: Consistent prosecution of corrupt enablers and large-scale traffickers. Regulation: Crackdown on rogue pharmacies and better tracking of prescription drugs. Prevention & Rehabilitation: School programs, community outreach, and expanded treatment centers (currently woefully inadequate). Economic Alternatives: Address root causes like youth unemployment. Public Awareness: Honest campaigns highlighting real dangers of “Exol-5” and similar drugs. Conclusion From Tramadol’s opioid grip to “Canadian” cannabis culture and now Exol-5’s anticholinergic highs, Nigeria’s drug crisis is mutating faster than responses can contain it. Exol-5 represents the dangerous new frontier — a legitimate medicine turned youth destroyer due to misuse and greed. Without urgent, multi-layered intervention — combining supply disruption, demand reduction, and socioeconomic support — an entire generation risks being lost to addiction. The time for half-measures is over. Nigeria’s future depends on winning this fight.